These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10671520)

  • 1. Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type I and HIV-1 expression.
    Thébault S; Gachon F; Lemasson I; Devaux C; Mesnard JM
    J Biol Chem; 2000 Feb; 275(7):4848-57. PubMed ID: 10671520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How the sequestration of a protein interferes with its mechanism of action: example of a new family of proteins characterized by a particular cysteine-rich carboxy-terminal domain involved in gene expression regulation.
    Thébault S; Mesnard JM
    Curr Protein Pept Sci; 2001 Jun; 2(2):155-67. PubMed ID: 12370022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
    Young TM; Wang Q; Pe'ery T; Mathews MB
    Mol Cell Biol; 2003 Sep; 23(18):6373-84. PubMed ID: 12944466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functions.
    Kusano S; Yoshimitsu M; Hachiman M; Ikeda M
    Virology; 2015 Dec; 486():219-27. PubMed ID: 26469549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activity.
    Gautier VW; Sheehy N; Duffy M; Hashimoto K; Hall WW
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16362-7. PubMed ID: 16260749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence requirement for the nucleolar localization of human I-mfa domain-containing protein (HIC p40).
    Thébault S; Basbous J; Gay B; Devaux C; Mesnard JM
    Eur J Cell Biol; 2000 Nov; 79(11):834-8. PubMed ID: 11139147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
    Cheng H; Tarnok J; Parks WP
    J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genome.
    Tanimura A; Dan S; Yoshida M
    J Virol; 1998 May; 72(5):3958-64. PubMed ID: 9557682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.
    Ou SH; Wu F; Harrich D; García-Martínez LF; Gaynor RB
    J Virol; 1995 Jun; 69(6):3584-96. PubMed ID: 7745706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110.
    Liu Y; Li J; Kim BO; Pace BS; He JJ
    J Biol Chem; 2002 Jun; 277(26):23854-63. PubMed ID: 11959860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct regions in human T-cell lymphotropic virus type I tax mediate interactions with activator protein CREB and basal transcription factors.
    Adya N; Giam CZ
    J Virol; 1995 Mar; 69(3):1834-41. PubMed ID: 7853524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
    New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.
    Lin HC; Bodkin M; Lal RB; Rabson AB
    J Virol; 1995 Nov; 69(11):7216-25. PubMed ID: 7474143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex regulation of HIC (Human I-mfa domain containing protein) expression.
    Reiss-Sklan E; Levitzki A; Naveh-Many T
    PLoS One; 2009 Jul; 4(7):e6152. PubMed ID: 19582149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression.
    Tissot C; Mechti N
    J Biol Chem; 1995 Jun; 270(25):14891-8. PubMed ID: 7797467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.